EFFECT OF FORMULATION PARAMETERS ON POROUS MICROSPHERE PREPARED BY EMULSIFICATION - SOLVENT EVAPORATION METHOD: EXPERIMENTAL DESIGN
Main Article Content
Abstract
Objective: Evaluate the potential simultaneous effect of critical formulation and process parameters on the particle mean size, encapsulation efficiency, sphericity, and porosity of the microspheres. Subjects and methods: Ethyl cellulose-based microspheres containing metronidazole were prepared by emulsification - solvent evaporation method. The experimental design was performed using the Box-Behnken model. Results: The encapsulation efficiency was influenced by polymer concentration and homogenization speed through an inverse rule. Formulation process with optimized conditions was established to produce microspheres with the sphericity of 0.90 ± 0.08, encapsulation efficiency of 14.44 ± 0.59 (%), particle mean size 153.14 ± 18.53 µm, and porosity 11.00 ± 1.74 mm3/g. Conclusion: The effect model of formulation and process parameters on microspheres’ properties was demonstrated, and the optimized preparation conditions were established. The study results supported the formulation process control to produce the porous microsphere. Thereby, researchers could estimate the proper conditions to achieve the porous microsphere with the desired property.
Article Details
Keywords
porous microsphere, emulsification - solvent evaporation method, experimental design
References
2. Minh-Quan L., Violet F., Paniagua C., et al. (2018), Penta-block copolymer microspheres: Impact of polymer characteristics and process parameters on protein release, International Journal of Pharmaceutics, 535,428-437.
3. Freitas S., Merkle H., Gander B. (2005), “Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology”, Journal of Controlled Release, 102(2), 313-332.
4. Li M., Rouaud O., Poncelet D. (2008), “Microencapsulation by solvent evaporation: state of the art for process engineering approaches”, International journal of pharmaceutics, 363(1-2), 26-39.